Advertisement
INDV vs SUPN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Hold and SUPN is a Hold.
INDV in -5.01% downward trend, declining for three consecutive days on October 16, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INDV declined for three days, in 154 of 217 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INDV as a result. In 61 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.
The Moving Average Convergence Divergence Histogram (MACD) for INDV turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
The Aroon Indicator for INDV entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for INDV's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in 144 of 210 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
INDV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-18.503) is normal, around the industry mean (10.234). P/E Ratio (11.267) is within average values for comparable stocks, (-6.027). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (2.152). Dividend Yield (0.059) settles around the average of (0.039) among similar stocks. P/S Ratio (3.330) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
SUPN's Indicator enters downward trend
The Aroon Indicator for SUPN entered a downward trend on September 24, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 140 similar instances where the Aroon Indicator formed such a pattern. In 102 of the 140 cases the stock moved lower. This puts the odds of a downward move at 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SUPN as a result. In 67 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for SUPN turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SUPN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where SUPN advanced for three days, in 228 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
SUPN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.139) is normal, around the industry mean (10.234). P/E Ratio (-19.729) is within average values for comparable stocks, (-6.027). Projected Growth (PEG Ratio) (0.900) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.863) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. SUPN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
INDV | SUPN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 47 | 64 | |
SMR RATING 1..100 | 64 | 94 | |
PRICE GROWTH RATING 1..100 | 58 | 76 | |
P/E GROWTH RATING 1..100 | 94 | 98 | |
SEASONALITY SCORE 1..100 | 90 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INDV's Valuation (5) in the null industry is in the same range as SUPN (37) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to SUPN’s over the last 12 months.
INDV's Profit vs Risk Rating (47) in the null industry is in the same range as SUPN (64) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to SUPN’s over the last 12 months.
INDV's SMR Rating (64) in the null industry is in the same range as SUPN (94) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to SUPN’s over the last 12 months.
INDV's Price Growth Rating (58) in the null industry is in the same range as SUPN (76) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to SUPN’s over the last 12 months.
INDV's P/E Growth Rating (94) in the null industry is in the same range as SUPN (98) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to SUPN’s over the last 12 months.
| INDV | SUPN | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 78% | 4 days ago 85% |
| Stochastic ODDS (%) | 4 days ago 73% | 4 days ago 74% |
| Momentum ODDS (%) | 4 days ago 67% | 4 days ago 69% |
| MACD ODDS (%) | 4 days ago 68% | 4 days ago 70% |
| TrendWeek ODDS (%) | 4 days ago 69% | 4 days ago 65% |
| TrendMonth ODDS (%) | 4 days ago 68% | 4 days ago 64% |
| Advances ODDS (%) | 8 days ago 69% | 8 days ago 72% |
| Declines ODDS (%) | 4 days ago 71% | 4 days ago 64% |
| BollingerBands ODDS (%) | 4 days ago 76% | 4 days ago 59% |
| Aroon ODDS (%) | 4 days ago 65% | 4 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INDV’s FA Score shows that 1 FA rating(s) are green while SUPN’s FA Score has 0 green FA rating(s).
- INDV’s FA Score: 1 green, 4 red.
- SUPN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INDV’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 4 bullish TA indicator(s).
- INDV’s TA Score: 4 bullish, 4 bearish.
- SUPN’s TA Score: 4 bullish, 4 bearish.
Price Growth
INDV (@Pharmaceuticals: Generic) experienced а -9.43% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was -11.23% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.66%. For the same industry, the average monthly price growth was -7.05%, and the average quarterly price growth was +9.07%.
Reported Earning Dates
INDV is expected to report earnings on Oct 29, 2026.
SUPN is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-4.66% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PPTY | 31.77 | 0.07 | +0.23% |
| US Diversified Real Estate ETF (PPTY) | |||
| ODDZ | 20.66 | N/A | N/A |
| Corgi Sports Betting & Gambling ETF (ODDZ) | |||
| SUSL | 136.20 | -1.55 | -1.13% |
| iShares ESG MSCI USA Leaders ETF (SUSL) | |||
| JSTC | 22.41 | -0.27 | -1.20% |
| Adasina Social Justice All Cap Global ETF (JSTC) | |||
| HYDR | 37.01 | -1.00 | -2.63% |
| Global X Hydrogen ETF (HYDR) | |||
INDV and
Correlation & Price change
A.I.dvisor indicates that over the last year, INDV has been loosely correlated with SUPN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INDV jumps, then SUPN could also see price increases.
| Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
|---|---|---|---|---|
| INDV | 100% | -3.48% | ||
| SUPN - INDV | 39% Loosely correlated | -4.27% | ||
| EBS - INDV | 31% Poorly correlated | -11.14% | ||
| AMRX - INDV | 30% Poorly correlated | -0.36% | ||
| XERS - INDV | 28% Poorly correlated | +2.38% | ||
| ELAN - INDV | 27% Poorly correlated | +0.04% | ||
More | ||||
SUPN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PRGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PRGO could also see price increases.
| Ticker / NAME | Correlation To SUPN | 1D Price Change % | ||
|---|---|---|---|---|
| SUPN | 100% | -4.27% | ||
| PRGO - SUPN | 48% Loosely correlated | +0.91% | ||
| INDV - SUPN | 38% Loosely correlated | -3.48% | ||
| ELAN - SUPN | 33% Loosely correlated | +0.04% | ||
| ANIP - SUPN | 33% Poorly correlated | +0.01% | ||
| XERS - SUPN | 29% Poorly correlated | +2.38% | ||
More | ||||